Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies

Name: Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies
Published: 2014
License: Public Domain

Case Comprehensive Cancer Center · 2014

ClinicalTrials.gov · Datasets · License: Public Domain · 2014

Open Source ↗

acute-myeloid-leukemia multiple-myeloma

acute myeloid leukemia, hematologic malignancies, acute lymphocytic leukemia, non hodgkin lymphoma, hodgkin lymphoma, multiple myeloma, myelodysplastic syndrome, chronic lymphocytic leukemia, chronic myeloid leukemia, myelofibrosis, myeloproliferative syndrome, interventional

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies

Related documents